Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000316b RIPK4
Assay data:1 Tested
SummaryRelated BioAssays by Target
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000702a RIPK4
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000178b RIPK4
Selectivity interaction (Enzymatic assay) EUB0000178b RIPK4
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition of human wild-type partial length RIPK4 (M1 to V303 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control
SummaryPubMed CitationRelated BioAssays by Target
Binding affinity to human RIPK4
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
RIPK4 DiscoveRx kinase panel
KinomeScan assay: inhibition of RIPK4
Assay data:1 Active, 108 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
ANKRD3(RIP4LGN1) Takeda global kinase panel
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition of human RIPK4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control
Inhibition of DNA-tagged human RIPK4 assessed as percent of control at 50000 nM by qPCR analysis relative to control
Inhibition of human RIPK4 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control
Inhibition of human partial length RIPK4 (M1 to V303 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by kinome scan method relative to control
Inhibition of human RIPK4 using histone H2A as substrate in presence of [gamma-33P]-ATP by hotspot kinase assay
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Binding affinity to wild-type human partial length RIPK4 (M1 to V303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control
Assay data:2 Tested
Inhibition of wild-type human partial length RIPK4 (M1 to V303 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control
Binding affinity to wild-type human partial length RIPK4 (M1 to V303 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control
Inhibition of wild-type human partial length RIPK4 (M1 to V303 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on